» Download Public Reports
About 2 800 reports
- Industry report
- June 2013
- 10 pages
... protein production is hindered by: Poor stability, aggregation, & low yields Major discovery/technical basis of s-gap: Combine protein chemistry with glycobiology to alleviate protein production ...
June 2013
... Cands in either europe or the united states. Approvals by the ema may not be indicative of what the fda may require for approval. Regulatory requirements governing gene and cell therapy products have ...
May 2013
... And production of rare, fully human monoclonal antibodies are offered by vivalis. Through these programs, vivalis receives payments associated with the funding of discovery research, an upfront payment, clinical ...
May 2013
... Be treated as a unique entity diclofenac = monoclonal antibodies shown within the circles: the reference product and each biosimilar has different post-translational modifications (in this case ...
May 2013
... Enterprises, inc.And rt speciality register now the consumer demand for non-gmo foods & dietary supplements isat an all time high. Gmo labeling laws are pending in many states.Whole foods has launched a gmo ...
May 2013
... Therapeutics for folding diseases or folding solutions are difficult to develop because proteins are moving targets }disease or misfolding n o ye s -high throughput readout signal -- yes/no decrease ...
May 2013
... Derived neurotrophic factor and brain-derived neurotrophic factor, thus they are referred to as Msc-ntf Cells, or nurown. Autologous adult stem cell therapy is free of the immune-related issues associated ...
April 2013
... By organizing different workshops on cellular and molecular biology assays in order to explore the effect of physical and chemical agents on human dna by analysing chromosomal alterations. Why 1. Dna ...
April 2013
... From funding. The doc/nist will review research using human embryonic stem cell lines that it supports and conducts in accordance with the common rule and nist implementing procedures, as appropriate ...
» Purchase Premium Reports
(From $ 125 - $ 6 995)
About 800 reports
- $ 6 995
- Industry report
- May 2013
- by iData Research, Inc.
Declining sales of specific market products has resulted in decelerating growth of the total U.S. denta bone graft substitute and other biomaterials market in 2012. In 2012, the total U.S. market for dental ...
May 2013
$ 6 860
Many diseases such as cardiovascular disorders, diabetes or neurodegenerative diseases are the consequences of dysfunction of specific cells. Strategies were developed to repair or regenerate the damaged ...
April 2013
$ 6 000
Finding Opportunities in a Changing Competitive and Patent Landscape This research service evaluates the U.S. qPCR reagents market from 2010 to 2017. The mature qPCR reagents market remains dynamic due ...
May 2013
$ 4 060
Many diseases such as cardiovascular disorders, diabetes or neurodegenerative diseases are the consequences of dysfunction of specific cells. Strategies were developed to repair or regenerate the damaged ...
May 2013
$ 2 995
The Antibody Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the antibody partnering deals and agreements entered into by the worlds leading healthcare ...
April 2013
$ 2 795
The Pharmacogenomic Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the pharmacogenomic partnering deals and agreements entered into by the worlds ...
June 2013
$ 2 488
Global Vaccine Market to 2017 - Market Size, Growth and Forecasts in Over 70 Countries is a comprehensive publication that enables readers the critical perspectives to be able to evaluate the world market ...
